SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, announced the promotion of Dr. Vishwa Srivastava to president and the appointment of Gary Lo as chief financial officer, according to a company announcement carried by NEWMEDIAWIRE. The leadership changes come as the company advances international expansion plans for its SSi Mantra surgical robotic system and works through key regulatory processes in the United States and Europe.
Srivastava, who previously served as CEO of the company’s Asia Pacific operations, will focus on building the U.S. business and leading global operations. Both executives are based in the United States. Lo brings more than three decades of financial leadership experience across technology companies, including the medical technology sector, with expertise in capital markets, financial planning and strategic growth. The appointments signal a deliberate effort to strengthen both commercial execution and financial management as SS Innovations seeks to scale its robotic surgery business globally.
The leadership moves matter because they come at a critical juncture for the company. SS Innovations is responding to questions from the U.S. Food and Drug Administration regarding its 510(k) premarket notification while pursuing CE marking certification in the European Union. Those regulatory milestones are essential for market access in two of the world’s largest health care markets. The company is also finalizing a pipeline of additional health care technologies at its research and development facility in India, with plans to introduce them in the coming months. A U.S.-based president with Asia Pacific experience and a CFO with medical technology and capital markets expertise could help the company navigate both regulatory reviews and investor expectations.
SS Innovations develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. Its product range includes the proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. Headquartered in India, SS Innovations is a U.S. company focused on expanding the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. More information is available at ssinnovations.com and LinkedIn.
The SSi Mantra is a modular, multi-arm system with advanced technology features, including 3 to 5 modular robotic arms, an open-faced ergonomic surgeon command center, a large 3D 4K monitor, a touch panel monitor for all patient related information display, a virtual real-time image of the robotic patient side arm carts, and the ability for superimposition of 3D models of diagnostic imaging. The optional SSi MantrAsana tele-surgeon console is a portable, compact alternative to the standard surgeon command center that is intended to provide equivalent control functionality while enabling enhanced portability, ergonomic flexibility, and telesurgery capability. The system utilizes over 40 different types of robotic endo-surgical instruments to support different specialties, including cardiac surgery, and 5mm instruments for the pediatric population and ENT surgeries. A vision cart is designed to provide the table-side team with the same magnified 3D 4K view as the surgeon to provide better safety and efficiency. The SSi Mantra has been clinically validated in India in more than 190 different types of surgical procedures.
For readers and industry observers, the executive appointments provide a clearer picture of how SS Innovations intends to convert its clinical validation and product portfolio into broader market adoption. The company’s ability to satisfy FDA questions and secure CE marking will determine whether its cost-effective robotic surgery vision can reach hospitals in the U.S. and Europe. The full announcement is available through https://nnw.fm/dX3qc, and the original release can be viewed at www.newmediawire.com.
